Phase 3 Readout~month

Phase 3 Topline: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficac

Indication
Parkinson's Disease

Other upcoming events for PRTA

Phase 3 ReadoutPhase 3 Topline: Optimizing Pain Treatment in Children On Mechanical Ventilation

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficac — PRTA Phase 3 Readout | BioSniper